|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01536639 |
|
Date of registration:
|
16/02/2012 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes
|
|
Scientific title:
|
Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes |
|
Date of first enrolment:
|
January 2006 |
|
Target sample size:
|
454 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01536639 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Slovakia
| | | | | | | |
|
Contacts
|
|
Name:
|
Global Clinical Registry (GCR, 1452) |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Novo Nordisk A/S |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subjects with type 2 diabetes
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes Mellitus, Type 2
|
|
Diabetes
|
|
Intervention(s)
|
|
Drug: biphasic insulin aspart 30
|
|
Primary Outcome(s)
|
|
HbA1c (glycosylated haemoglobin)
|
|
Secondary Outcome(s)
|
|
Hypoglycaemia
|
|
Post-prandial glucose (PPG)
|
|
Weight
|
|
Fasting plasma glucose (FPG)
|
|
Adverse events
|
|
Secondary ID(s)
|
|
BIASP-1929
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|